SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-015549
Filing Date
2019-08-13
Accepted
2019-08-13 16:36:23
Documents
3
Period of Report
2019-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k081219_inmunebio.htm 8-K 17430
2 PRESS RELEASE, DATED AUGUST 12, 2019 f8k081219ex99-1_inmunebio.htm EX-99.1 79219
3 GRAPHIC image_001.jpg GRAPHIC 5419
  Complete submission text file 0001213900-19-015549.txt   105400
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 191021184
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1